The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Hoping for a baby? New DNA test identifies fertility risk factors in women

| | January 30, 2017

[The DNA test] Fertilome was launched in January 2017 after being in the works for eight years. The company behind it, New York-based Celmatix, says it’s the first comprehensive test that screens for risk factors associated with female fertility.

Typically, age is the main factor that doctors consider when thinking about a woman’s fertility…[But] genetics could be linked to risk factors for endometriosis, polycystic ovarian syndrome, and primary ovarian insufficiency that can be a precursor to early menopause.

Celmatix CEO Piraye Yurttas Beim [stated] that there are two different situations in which she’s hoping the Fertilome test will be useful:

  • For couples looking for clarity on why they’re having trouble conceiving
  • For women who are considering freezing their eggs so they can have a baby when they’re ready

For that second group, the genetics test could be a big help in determining who might actually benefit from the procedure. That could keep people from paying for the procedure who might not end up needing it because they end up conceiving on their own, a frequent result for egg freezing.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: There’s now a genetic test for women’s fertility called Fertilome

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend